Hae‐Ji Kang

509 total citations
54 papers, 420 citations indexed

About

Hae‐Ji Kang is a scholar working on Epidemiology, Parasitology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hae‐Ji Kang has authored 54 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 27 papers in Parasitology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hae‐Ji Kang's work include Toxoplasma gondii Research Studies (25 papers), Herpesvirus Infections and Treatments (22 papers) and Influenza Virus Research Studies (11 papers). Hae‐Ji Kang is often cited by papers focused on Toxoplasma gondii Research Studies (25 papers), Herpesvirus Infections and Treatments (22 papers) and Influenza Virus Research Studies (11 papers). Hae‐Ji Kang collaborates with scholars based in South Korea, United States and India. Hae‐Ji Kang's co-authors include Fu‐Shi Quan, Ki‐Back Chu, Su‐Hwa Lee, Eun‐Kyung Moon, Dong‐Hun Lee, Hui Jin, Sang‐Moo Kang, Hyunwoo Park, Dong‐Hun Lee and Hyo‐Jick Choi and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Vaccine.

In The Last Decade

Hae‐Ji Kang

52 papers receiving 419 citations

Peers

Hae‐Ji Kang

EPIDE

PARAS

PHEOH

IMMUN

Samira Dodangeh Iran

Céline Dard France

Kyoung-Ju Song South Korea

David Garcia-Tapia United States

Jennifer Conlon Canada

Valérie Conseil France

Xunhui Zhuo China

David Arranz-Solís United States

Daniel Portsmouth Austria

Adnan Yüksel Gürüz Türkiye

Samira Dodangeh Iran

Hae‐Ji Kang

157 ×0.6

EPIDE

291 ×1.4

PARAS

33 ×0.4

39 ×0.6

PHEOH

43 ×0.7

IMMUN

Citations per year, relative to Hae‐Ji Kang Hae‐Ji Kang (= 1×) peers Samira Dodangeh

Countries citing papers authored by Hae‐Ji Kang

Since Specialization

Citations

This map shows the geographic impact of Hae‐Ji Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hae‐Ji Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hae‐Ji Kang more than expected).

Fields of papers citing papers by Hae‐Ji Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hae‐Ji Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hae‐Ji Kang. The network helps show where Hae‐Ji Kang may publish in the future.

Co-authorship network of co-authors of Hae‐Ji Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hae‐Ji Kang. A scholar is included among the top collaborators of Hae‐Ji Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hae‐Ji Kang. Hae‐Ji Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Hae‐Ji & Fu‐Shi Quan. (2025). Recombinant vaccinia virus expressing MIC8, AMA1, or RON4 induce protection against Toxoplasma gondii ME49 strain infection. Acta Tropica. 270. 107812–107812.

Kang, Hae‐Ji & Fu‐Shi Quan. (2025). Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of Toxoplasma gondii. Vaccines. 13(8). 862–862. 1 indexed citations

Kang, Hae‐Ji, et al.. (2024). Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2. Vaccine. 43(Pt 2). 126530–126530. 3 indexed citations

Chu, Ki‐Back, et al.. (2024). Crossprotection Induced by Virus-Like Particles Containing Influenza Dual-Hemagglutinin and M2 Ectodomain. Nanomedicine. 19(9). 741–754. 2 indexed citations

Chu, Ki‐Back, et al.. (2024). Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice. Nanomedicine. 19(29). 2437–2446. 5 indexed citations

Kang, Hae‐Ji, et al.. (2024). Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8. Acta Tropica. 261. 107501–107501. 5 indexed citations

Kang, Hae‐Ji, et al.. (2023). The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques. PubMed. 61(4). 418–427. 3 indexed citations

Chu, Ki‐Back, Hae‐Ji Kang, Su‐Hwa Lee, et al.. (2023). Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein. PLoS ONE. 18(4). e0283928–e0283928. 12 indexed citations

Chu, Ki‐Back, Hae‐Ji Kang, Su‐Hwa Lee, et al.. (2022). Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei. Biomedicines. 10(9). 2289–2289. 1 indexed citations

10.

Lee, Su‐Hwa, et al.. (2021). Respiratory virus deterrence induced by modified mask filter. PLoS ONE. 16(9). e0257827–e0257827. 4 indexed citations

11.

Kang, Hae‐Ji, Ki‐Back Chu, Su‐Hwa Lee, et al.. (2020). Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins. Parasite Immunology. 43(1). e12799–e12799. 10 indexed citations

12.

Lee, Su‐Hwa, Ki‐Back Chu, Hae‐Ji Kang, et al.. (2020). Virus‐like particles expressing Plasmodium berghei MSP‐8 induce protection against P. berghei infection. Parasite Immunology. 42(11). e12781–e12781. 9 indexed citations

13.

Lee, Su‐Hwa, Hae‐Ji Kang, Ki‐Back Chu, et al.. (2020). Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice. Microbial Pathogenesis. 142. 104090–104090. 16 indexed citations

14.

Kang, Hae‐Ji, et al.. (2020). Influenza vaccine efficacy induced by orally administered recombinant baculoviruses. PLoS ONE. 15(5). e0233520–e0233520. 10 indexed citations

15.

Lee, Dong‐Hun, Ki‐Back Chu, Hae‐Ji Kang, Su‐Hwa Lee, & Fu‐Shi Quan. (2019). Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice. Korean Journal of Parasitology. 57(2). 93–99. 4 indexed citations

16.

Kang, Hae‐Ji, Ki‐Back Chu, Dong‐Hun Lee, et al.. (2019). Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs. PLoS ONE. 14(6). e0216871–e0216871. 33 indexed citations

17.

Kang, Hae‐Ji, Su‐Hwa Lee, Ki‐Back Chu, Dong‐Hun Lee, & Fu‐Shi Quan. (2018). Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection. Korean Journal of Parasitology. 56(5). 429–435. 9 indexed citations

18.

Chu, Ki‐Back, et al.. (2018). The resistance againstTrichinella spiralisinfection induced by primary infection with respiratory syncytial virus. Parasitology. 146(5). 634–642. 3 indexed citations

19.

Lee, Su‐Hwa, Hae‐Ji Kang, Dong‐Hun Lee, Sang‐Moo Kang, & Fu‐Shi Quan. (2018). Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Vaccine. 36(38). 5692–5700. 35 indexed citations

20.

Sames, William J., Terry A. Klein, Heung-Chul Kim, et al.. (2010). Serological Surveillance of Scrub Typhus, Murine Typhus, and Leptospirosis in Small Mammals Captured at Twin Bridges Training Area, Gyeonggi Province, Republic of Korea, 2005–2007. Military Medicine. 175(1). 48–54. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact